Updated Jul 16, 2026
BENZENO SHARON has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $4.33M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | ADPT | Adaptive Biotechnologies Corp | S — Open-market sale | 154.8K | $21.14 | $3.27M |
| 2026-06-30 | ADPT | Adaptive Biotechnologies Corp | M — Option exercise | 51.6K | $8.12 | $419K |
| 2026-06-30 | ADPT | Adaptive Biotechnologies Corp | M — Option exercise | 24.9K | $3.99 | $100K |
| 2026-06-30 | ADPT | Adaptive Biotechnologies Corp | M — Option exercise | 24.9K | $8.46 | $211K |
| 2026-06-30 | ADPT | Adaptive Biotechnologies Corp | M — Option exercise | 1.8K | $12.14 | $22K |
| 2026-06-30 | ADPT | Adaptive Biotechnologies Corp | S — Open-market sale | 11.0K | $21.00 | $232K |
| 2026-06-30 | ADPT | Adaptive Biotechnologies Corp | M — Option exercise | 11.0K | $12.14 | $134K |
| 2026-03-14 | ADPT | Adaptive Biotechnologies Corp | S — Open-market sale | 63.1K | $13.17 | $831K |
| 2026-03-07 | ADPT | Adaptive Biotechnologies Corp | A — Grant or award | 39.1K | $0.00 |
BENZENO SHARON is a corporate insider — currently tracked as Chief Commercial Ofc Imm Med of Adaptive Biotechnologies Corp (ADPT). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($4.33M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live BENZENO SHARON profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.